Evidence map›Paper›PMID 28074026›Full record

ArticlemBio2017

Promyelocytic Leukemia Protein (PML) Controls Listeria monocytogenes Infection.

David Ribet, Valérie Lallemand-Breitenbach, Omar Ferhi, Marie-Anne Nahori, Hugo Varet, Hugues de Thé, Pascale Cossart

Open access · goldAbstract read
In one paragraph

Article in mBio, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Gut microbes · 2025
    Article
  2. Review
  3. Review
  4. Frontiers in immunology · 2023
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Microbiology spectrum · 2018
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. PML is a ROS sensor activating p53 upon oxidative stress.The Journal of experimental medicine · 2017
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

David RibetInstitut Pasteur, Unité des Interactions Bactéries-Cellules, Paris, France.
Valérie Lallemand-BreitenbachInserm, CNRS, Université Paris Diderot, Institut Universitaire Hématologie, U944/UMR7212, Hôpital St. Louis, Paris, France.
Omar FerhiInserm, CNRS, Université Paris Diderot, Institut Universitaire Hématologie, U944/UMR7212, Hôpital St. Louis, Paris, France.
Marie-Anne NahoriInstitut Pasteur, Unité des Interactions Bactéries-Cellules, Paris, France.
Hugo VaretInstitut Pasteur, Plate-forme Transcriptome et Epigenome, Biomics, Centre d'Innovation et Recherche Technologique (Citech), Paris, France.
Hugues de ThéInserm, CNRS, Université Paris Diderot, Institut Universitaire Hématologie, U944/UMR7212, Hôpital St. Louis, Paris, France hugues.dethe@inserm.fr pascale.cossart@pasteur.fr.
Pascale CossartInstitut Pasteur, Unité des Interactions Bactéries-Cellules, Paris, France hugues.dethe@inserm.fr pascale.cossart@pasteur.fr.
Collège de France · FRInstitut Pasteur · FRInserm · FR

Funding

European Research Council 233348
6 · The paper itself

Abstract

The promyelocytic leukemia protein (PML) is the main organizer of stress-responsive subnuclear structures called PML nuclear bodies. These structures recruit multiple interactors and modulate their abundance or their posttranslational modifications, notably by the SUMO ubiquitin-like modifiers. The involvement of PML in antiviral responses is well established. In contrast, the role of PML in bacterial infection remains poorly characterized. Here, we show that PML restricts infection by the pathogenic bacterium Listeria monocytogenes but not by Salmonella enterica serovar Typhimurium. During infection, PML undergoes oxidation-mediated multimerization, associates with the nuclear matrix, and becomes de-SUMOylated due to the pore-forming activity of the Listeria toxin listeriolysin O (LLO). These events trigger an antibacterial response that is not observed during in vitro infection by an LLO-defective Listeria mutant, but which can be phenocopied by specific induction of PML de-SUMOylation. Using transcriptomic and proteomic microarrays, we also characterized a network of immunity genes and cytokines, which are regulated by PML in response to Listeria infection but independently from the listeriolysin O toxin. Our study thus highlights two mechanistically distinct complementary roles of PML in host responses against bacterial infection. IMPORTANCE: The promyelocytic leukemia protein (PML) is a eukaryotic protein that can polymerize in discrete nuclear assemblies known as PML nuclear bodies (NBs) and plays essential roles in many different cellular processes. Key to its function, PML can be posttranslationally modified by SUMO, a ubiquitin-like modifier. Identification of the role of PML in antiviral defenses has been deeply documented. In contrast, the role of PML in antibacterial defenses remains elusive. Here, we identify two mechanistically distinct complementary roles of PML in antibacterial responses against pathogens such as Listeria: (i) we show that PML regulates the expression of immunity genes in response to bacterial infection, and (ii) we unveil the fact that modification of PML SUMOylation by bacterial pore-forming toxins is sensed as a danger signal, leading to a restriction of bacterial intracellular multiplication. Taken together, our data reinforce the concept that intranuclear bodies can dynamically regulate important processes, such as defense against invaders.

Indexed as

Host-Pathogen InteractionsProtein Processing, Post-TranslationalAnimalsBacterial ToxinsCells, CulturedGene Expression ProfilingHeat-Shock ProteinsHemolysin ProteinsHumansListeria monocytogenesMiceMicroarray AnalysisPromyelocytic Leukemia ProteinProtein MultimerizationProteomeSalmonella typhimuriumBacterial ToxinsHeat-Shock ProteinsHemolysin ProteinshlyA protein, Listeria monocytogenesPromyelocytic Leukemia ProteinProteome

Identifiers

PMID28074026
PMCPMC5225316
OpenAlexW2570842249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.